(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 4.48% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.06%.
Treace Medical Concepts's revenue in 2026 is $207,318,000.On average, 7 Wall Street analysts forecast TMCI's revenue for 2026 to be $13,645,381,772, with the lowest TMCI revenue forecast at $12,982,379,957, and the highest TMCI revenue forecast at $14,100,141,334. On average, 7 Wall Street analysts forecast TMCI's revenue for 2027 to be $14,680,754,469, with the lowest TMCI revenue forecast at $13,732,311,560, and the highest TMCI revenue forecast at $15,803,056,954.
In 2028, TMCI is forecast to generate $15,718,722,085 in revenue, with the lowest revenue forecast at $14,368,066,724 and the highest revenue forecast at $16,968,175,603.